# Agence Marocaine du Médicament et des Produits de Santé (AMMPS)

Source: https://onco.cc/institutions/ammps-morocco/  
OnCo record `ammps-morocco` (Institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Morocco's medicines regulator, created by law 10-22 to replace the health ministry's Direction du Médicament et de la Pharmacie. It authorises and monitors medicines and other health products, sets the essential medicines list with other departments, and runs pharmacovigilance.

## Summary

Le360 reported on 1 March 2023 that bill 10-22 creating the agency had been adopted the day before, by the House of Representatives according to its headline and by the House's social sectors committee according to its text; the health minister of the time described its role as carrying out the state's policy on pharmaceutical sovereignty and on the availability, safety and quality of medicines and health products. Under the bill it coordinates national pharmaceutical policy, regulates and inspects the sector, oversees narcotics and psychotropic substances, promotes local manufacture of generics and biosimilars, and draws up and updates the list of essential medicines in coordination with the sectors concerned. The coordinates are a Rabat city point.

The agency's first board meeting, chaired by the head of government, approved its strategy, 2025 budget and organisation; at the second, on 17 December 2025, the health minister reviewed its 2025 management report and its programme for 2026. In a May 2026 interview with Finances News Hebdo, a pharmaceutical industry analyst, Abdelmadjid Belaïche, named Professor Samir Ahid as its director, said it now covers medicines, vaccines, biological products, medical devices, cosmetics, supplements and diagnostic reagents, has taken over pharmacovigilance from the poison and pharmacovigilance centre, and works towards WHO maturity level 3, and listed decrees of 2026 on import visas for medicines (2.26.28) and on biomedical research (2.26.223). The agency's own site did not answer when this record was written, so no approval times or reliance procedures are stated here.

## Fields

- Kind: Institution
- Last checked: 2026-11-11
- Also known as: AMMPS; Moroccan Agency of Medicines and Health Products; Direction du Médicament et de la Pharmacie; DMP
- City: Rabat, MA
- Type: government
- Website: https://ammps.sante.gov.ma

## Sources

- Le360: House of Representatives adopts bill 10-22 (1 March 2023): https://fr.le360.ma/politique/chambre-des-representants-adoption-du-projet-de-loi-sur-la-creation-de-lagence-des-medicaments_FPLLIXKSPBCEPE6TPIZ5B7CFQQ/
- Hespress: second board meeting of the AMMPS (17 December 2025): https://fr.hespress.com/454502-ca-ammps-tahraoui-fixe-le-cap-de-la-souverainete-sanitaire.html
- Finances News Hebdo: interview on pharmaceutical regulation (18 May 2026): https://www.fnh.ma/article/actualite-economique/reglementation-pharmaceutique-maroc-pharmacovigilance-reforme

## Connected records

- terms: [WHO Essential Medicines List for cancer](https://onco.cc/terms/who-essential-medicines/)
- institutions: [Caisse Nationale de Sécurité Sociale (CNSS), Morocco](https://onco.cc/institutions/cnss-morocco/), [Ministère de la Santé et de la Protection Sociale (Morocco)](https://onco.cc/institutions/ministry-of-health-morocco/)

---
JSON: https://onco.cc/api/v1/entities/ammps-morocco.json